Floctafenine

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

{{Drugbox | drug_name = Floctafenine | IUPAC_name = 2,3-Dihydroxypropyl 2-{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate | image = Floctafinine Wiki Str.png

| alt = | caption =

| tradename = | Drugs.com = International Drug Names | MedlinePlus = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number = 23779-99-9 | ATCvet = | ATC_prefix = N02 | ATC_suffix = BG04 | PubChem = 3360 | DrugBank_Ref =  ☒N | DrugBank = DB08976 | ChemSpiderID = 3243


| C=20 | H=17 | F=3 | N=2 | O=4 | molecular_weight = 406.355 g/mol | smiles = FC(F)(F)c1cccc2c(ccnc12)Nc3ccccc3C(=O)OCC(O)CO | InChI = 1/C20H17F3N2O4/c21-20(22,23)15-6-3-5-13-17(8-9-24-18(13)15)25-16-7-2-1-4-14(16)19(28)29-11-12(27)10-26/h1-9,12,26-27H,10-11H2,(H,24,25) | InChIKey = APQPGQGAWABJLN-UHFFFAOYAH | StdInChI = 1S/C20H17F3N2O4/c21-20(22,23)15-6-3-5-13-17(8-9-24-18(13)15)25-16-7-2-1-4-14(16)19(28)29-11-12(27)10-26/h1-9,12,26-27H,10-11H2,(H,24,25) | StdInChIKey = APQPGQGAWABJLN-UHFFFAOYSA-N }}

WikiDoc Resources for Floctafenine

Articles

Most recent articles on Floctafenine

Most cited articles on Floctafenine

Review articles on Floctafenine

Articles on Floctafenine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Floctafenine

Images of Floctafenine

Photos of Floctafenine

Podcasts & MP3s on Floctafenine

Videos on Floctafenine

Evidence Based Medicine

Cochrane Collaboration on Floctafenine

Bandolier on Floctafenine

TRIP on Floctafenine

Clinical Trials

Ongoing Trials on Floctafenine at Clinical Trials.gov

Trial results on Floctafenine

Clinical Trials on Floctafenine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Floctafenine

NICE Guidance on Floctafenine

NHS PRODIGY Guidance

FDA on Floctafenine

CDC on Floctafenine

Books

Books on Floctafenine

News

Floctafenine in the news

Be alerted to news on Floctafenine

News trends on Floctafenine

Commentary

Blogs on Floctafenine

Definitions

Definitions of Floctafenine

Patient Resources / Community

Patient resources on Floctafenine

Discussion groups on Floctafenine

Patient Handouts on Floctafenine

Directions to Hospitals Treating Floctafenine

Risk calculators and risk factors for Floctafenine

Healthcare Provider Resources

Symptoms of Floctafenine

Causes & Risk Factors for Floctafenine

Diagnostic studies for Floctafenine

Treatment of Floctafenine

Continuing Medical Education (CME)

CME Programs on Floctafenine

International

Floctafenine en Espanol

Floctafenine en Francais

Business

Floctafenine in the Marketplace

Patents on Floctafenine

Experimental / Informatics

List of terms related to Floctafenine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Floctafenine is a non-steroidal anti-inflammatory drug (NSAID).

Synthesis

700pxDE 1815467 ; eidem, U.S. Patent 3,644,368 Roussel Uclaf; [1]
700pxDE 1815467 ; eidem, U.S. Patent 3,644,368 Roussel Uclaf; [1]

The scheme involves first the conversion of ortho-trifluoromethyl aniline (1) to a quinolol. The compound is thus condensed with EMME (Ethoxy Methylene Malonic Diethyl Ester) and cyclized thermally (2). That intermediate is then saponified; the resulting acid is decarboxylated and finally converted to the 4-chloroquinoline (3) by reaction with phosphorus oxychloride. The displacement of chlorine with methyl anthranilate (4) then affords the coupled intermediate (5). An ester interchange of that product with glycerol leads to the glyceryl ester. There is thus obtained the NSAID floctafenine.

See also

References


Template:Analgesic-stub